New Product Launches to Support HOLX Stock Amid Macro Issues

Hologic (HOLX) has been gaining from new strategic product launches across Diagnostics and Breast Health. However, macroeconomic issues and unfavorable FX headwinds continue to impede growth. The stock carries a Zacks Rank #3 (Hold) currently.Major Driving Factors Behind Growth of HOLX StockIn Breast Health, Hologic’s latest advancements have been generating significant interest. The new Envision Mammography Platform, the first FDA-approved mammography technology of its kind, offers an industry-leading 2.5- ...